Abstract:
PURPOSE: A composition containing Torilidis Fructus extract for enhancing immunity is provided to enhance TLR-2 and TLR-4 activity in immunocytes. CONSTITUTION: A pharmaceutical composition for enhancing immunity contains Torilidis Fructus extract as an active ingredient. The Torilidis Fructus extract is isolated using water, low alcohol of C1-C4 or mixture solvent thereof. The Torilidis Fructus extract is contained in the composition in 0.1-50 weight%. A functional health food for enhancing immunity contains Torilidis Fructus extract as an active ingredient. The functional health food is used in the form of powder, granule, tablet, capsule or beverage. A feed additive for enhancing immunity of animal contains the Torilidis Fructus extract as an active ingredient.
Abstract:
PURPOSE: A composition containing Puerariae Radix extract for enhancing immunity is provided to prevent and suppress immune deficiency and to use a s food, medicinal product, and feed additive. CONSTITUTION: A pharmaceutical composition for enhancing immunity contains 0.1-50 weight% of Puerariae Radix extract as an active ingredient. The extract is isolated using water, low alcohol of 1-4 carbon atoms, or mixture solvent. A health food for enhancing immunity contains Puerariae Radix extract as an active ingredient. The health food is used in the form of powder, granule, tablet, capsule, or beverage. An animal feed additive for enhancing immunity contains the Puerariae Radix extract as an active ingredient.
Abstract:
A veterinary composition containing a Galla rhois extract or compound isolated from the extract is provided to prevent and treat respiratory and digestive diseases of pig. A veterinary composition for preventing and treating respiratory and digestive diseases of pig comprises a Galla rhois extract or compound isolated from the extract as an active ingredient. The extract is isolated using water, low alcohol of C1-C4 or their solvent. The compound is a compound selected from gallic acid, mixture of p-digallic acid and m-digallic acid, penta-O-galloyl glucose, ethyl gallate or mixture of ethyl p-digallate and ethyl m-digallate. The compound is denoted by the chemical formula 1, 2, 3, 4, or 5.
Abstract:
An extract of Mori Fructus is provided to increase NO secretion and cytokine expression, enhance the bacteria phagocytic effect, increase expression of many co-stimulatory molecules, express TLR-4, increase the expression of TLR-4(toll-like receptor 4) and CD14, and show the immunoglobulin increasing effect and B cells and T cells activity, thereby being used as a pharmaceutical composition and a health functional food for enhancing immunity. A pharmaceutical composition for enhancing immunity comprises an extract of Mori Fructus, which is extracted by using a polar solvent such as water, C1-4 alcohol and a mixture thereof. The composition further comprises a carrier, an excipient or a diluent. A health functional food for preventing and improving immunodepression comprises the extract of Mori Fructus.
Abstract:
An antibacterial composition containing the extract of Fraxinus rhynchophylla or compounds isolated therefrom is provided to inhibit growth of zoonoses-causing pathogenic bacteria with reduced toxicity and tolerance. An antibacterial composition for inhibiting growth of zoonoses-causing pathogenic bacteria contains the extract of Fraxinus rhynchophylla which is prepared with water, C1-C4 lower alcohol or a mixed solvent thereof, or compounds isolated from the Fraxinus rhynchophylla extract including esculetin(6,7-dihydroxy coumarin), fraxidin(6,7-dimethoxy-8-hydroxy coumarin), fraxetin(7,8-dihydroxy-6-methoxy coumarin), oleuropein, fraxidin 8-O-beta-D-glucopyranoside and escuside, wherein the zoonoses-causing pathogenic bacteria include Salmonella typhimurium.